Travere Therapeutics, Inc. (TVTX)

Travere Therapeutics Stock Forecast

Stock Price Forecast

The 12 analysts with 12-month price forecasts for Travere Therapeutics stock have an average target of 33.17, with a low estimate of 20 and a high estimate of 45. The average target predicts an increase of 67.53% from the current stock price of 19.80.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$20	$33.17	$35	$45
Change	+1.01%	+67.53%	+76.77%	+127.27%

Analyst Ratings

The average analyst rating for Travere Therapeutics stock from 13 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '24	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25
Strong Buy	5	4	4	4	4	4
Buy	3	6	6	6	6	8
Hold	4	3	3	3	2	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	12	13	13	13	12	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Anupam Rama JP Morgan	JP Morgan	Buy Maintains $42 → $44	Buy	Maintains	$42 → $44	+122.22%	Feb 26, 2025
Carly Kenselaar Citigroup	Citigroup	Strong Buy Maintains $31 → $35	Strong Buy	Maintains	$31 → $35	+76.77%	Feb 24, 2025
Prakhar Agrawal Cantor Fitzgerald	Cantor Fitzgerald	Buy Reiterates n/a	Buy	Reiterates	n/a	n/a	Feb 21, 2025
Greg Harrison Scotiabank	Scotiabank	Buy Maintains $27 → $32	Buy	Maintains	$27 → $32	+61.62%	Feb 12, 2025
Liisa Bayko Evercore ISI Group	Evercore ISI Group	Buy Maintains $33 → $45	Buy	Maintains	$33 → $45	+127.27%	Feb 12, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

372.84M

Increased by 59.90%

from 233.18M

Revenue Next Year

562.01M

Increased by 50.74%

from 372.84M

EPS This Year

-1.32

from -4.08

EPS Next Year

0.58

from -1.32

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	198.32M	131.84M	109.46M	145.24M	233.18M	372.84M	562.01M	675.74M
Revenue Growth	13.11%	-33.52%	-16.97%	32.69%	60.55%	59.90%	50.74%	20.24%
EPS	-3.56	-3.01	-4.37	-1.50	-4.08	-1.32	0.58	2.92
EPS Growth	-	-	-	-	-	-	-	404.70%
Forward PE	-	-	-	-	-	-	34.26	6.79
No. Analysts	-	-	-	-	-	17	15	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	444.4M	778.6M	1.1B
Avg	372.8M	562.0M	675.7M
Low	263.8M	379.3M	443.0M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	90.6%	108.8%	95.2%
Avg	59.9%	50.7%	20.2%
Low	13.1%	1.7%	-21.2%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-0.51	2.94	4.07
Avg	-1.32	0.58	2.92
Low	-2.15	-0.66	1.26

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	604.8%
Avg	-	-	404.7%
Low	-	-	118.7%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.